Risk factors and comorbidities in patients with psoriasis

Authors

Keywords:

psoriasis, comorbidity, risk factors, hospital care.

Abstract

A descriptive, cross-sectional and prospective study of 114 patients with diagnosis of psoriasis, assisted in the Dermatology Service of Dr. Juan Bruno Zayas Alfonso Teaching General Hospital in Santiago de Cuba was carried out from January, 2014 to March, 2016, with the aim of identifying the risk factors and the comorbidities in them. Most of the members of the case material corresponded to the age group 30 to 45 years and to the female sex; in a same way, the smoking habit, sedentarism and the overweight prevailed as risk factors, and hypertension, hepatic esteatosis, psychiatric and cardiovascular changes as associate morbidities. It could be concluded that patients with psoriasis require a comprehensive and multidisciplinary care due to the great comorbidities frequency, which limit even more their life quality.

Downloads

Download data is not yet available.

References

1. Arenas Guzmán R. Dermatología, atlas, diagnóstico y tratamiento. 5 ed. McGraw-Hill; 2012.

2. Ni C, Chiu M. Psoriasis and comorbidities: links and risks. Clin Cosmet Investig Dermatol. 2014 [citado 16/03/2018];7:119-34. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4000177/pdf/ccid-7-119.pdf

3. Santos Paim de Oliveira MF, de Olivera Rocha, Vieria Duarte G. Psoriasis: classical and emerging comorbidities. An Bras Dermatol. 2015[citado 16/03/2018];90(1):9-20. Disponible en: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962015000100009&lng=en&nrm=iso&tlng=en

4. Carrascosa JM, Rocamora V, Fernandez-Torres RM, Jimenez-Puya R, Moreno JC, Coll-Puigserver N, et al. Obesidad y psoriasis: naturaleza inflamatoria de la obesidad, relación entre psoriasis y obesidad e implicaciones terapéutica. Actas Dermosifiliogr. 2014; 105(1): 31-44.

5. National Psoriasis Foundation. Statistics [citado 16/03/2018]. Disponible en: https://www.psoriasis.org/content/statistics

6. Valdés Solís E, Colorado García LM, Lozano Nuevo JJ, Rubio Guerra F. Asociación entre la severidad de la psoriasis en placas y el síndrome metabólico. Med Int Méx. 2016 [citado 16/03/2018];32(2):190-200. Disponible en: https://www.medigraphic.com/pdfs/medintmex/mim-2016/mim162f.pdf

7. World Health Organization. Global Report on psoriasis. Geneva: WHO; 2016 [citado 16/03/2018]. Disponible en: http://www.who.int/iris/handle/10665/204417

8. Kimball AB, Leonardi C, Stahle M, Gulliver W, Chevrier M, Fakharzadeh S, et al. Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR). Br J Dermatol. 2014;171(1):137-47.

9. Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, Wolff K. Fitzpatrick. Dermatología en Medicina General. 8 ed. Buenos Aires: Editorial Médica Panamericana; 2012. p. 469-89.

10. Vanaclocha F, Crespo Erchiga V, Jiménez Puya R, Puig L, Sánchez Carazo J, Ferrán M, et al. Enfermedades inflamatorias mediadas por inmunidad y otras comorbilidades en pacientes con psoriasis. Características basales de la cohorte de pacientes con psoriasis del estudio AQUILES. Actas Dermosifiliogr. 2015 [citado 10/01/2018];106(1):35-43. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0001731014003391.pdf?locale=es_ES

11. Carrascosa JM, Belinchón I, de-la-Cueva P, Izu R, Luelmo J, Ruiz-Villaverde R. Recomendaciones de expertos para el tratamiento de la psoriasis en situaciones especiales. Actas Dermosifiliogr. 2015 [citado 10/01/2018];106(24):112-6. Disponible en: https://www.clinicalkey.es/service/content/pdf/watermarked/1-s2.0-S0001731014004839.pdf?locale=es_ES

12. López M. Asocian la psoriasis con la obesidad [citado 10/01/2018]. Disponible en: https://www.abc.es/salud/enfermedades/abci-estudio-gemelos-confirma-asociacion-psoriasis-obesidad-201604270204_noticia.html

13. Daudén E, Castañeda S, Suárez C, García-Campayod J, Blasco AJ, Aguilare MD, et al. Abordaje integral de la comorbilidad del paciente con psoriasis. Actas Dermosifiliogr. 2012;103(Supl 1):1-64.

14. Gerdes S, Zahl VA, Weichenthal M, Mrowietz U. Smoking and alcohol intake in severely affected patients with psoriasis in Germany. Dermatology. 2010;220(1):38-43.

15. Bonanad C, González-Parra E, Rivera R, Carrascosa JM, Daudén E, Olveira A, et al. Implicaciones clínicas, diagnósticas y terapéuticas de la psoriasis y enfermedad cardiovascular. Actas Dermosifiliogr. 2017;108(9):795-888.

16. Hugh J, Van Voorhees AS, Nijhawan RI, Bagel J, Lebwohl M, Blauvelt A, et al. From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies. J Am Acad Dermatol. 2014;70(1):168-77.

17. Rodríguez Zúñiga MJM, Cortez Franco F, Quijano Gomero E. Relación entre psoriasis y síndrome metabólico en Latinoamérica. Revisión sistemática y metaanálisis. Actas Dermosifiliogr. 2017;108(4):326-34.

18. Castro Ayarza JR, Casadiego EJ, Medina DC. Descripción de los pacientes con diagnóstico de psoriasis en un centro dermatológico de referencia de Bogotá, Colombia. Dermatol Rev Mex. 2017 [citado 10/01/2018];61(4):283-91. Disponible en: https://www.medigraphic.com/pdfs/derrevmex/rmd-2017/rmd174d.pdf

19. Pérez Armas R, Doural Estrada DM, Chávez Valera PL. Aspectos psicológicos para el manejo de la psoriasis. Revista Finlay. 2013 [citado 10/01/2018];3(4). Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/207/1153

20. Ortega-Hernández A, Restrepo-López N, Stefany Rosero Y, Úsuga-Úsuga F, Correa-Londoño LA, et al. Características epidemiológica, clínica e histopatológicas de pacientes con psoriasis y factores asociados con las formas vulgar y pustulosa. Dermatol Rev Mex. 2018 [citado 10/01/2018];62(3):193-205. Disponible en: https://www.medigraphic.com/pdfs/derrevmex/rmd-2018/rmd183b.pdf

Downloads

Published

2019-06-11

How to Cite

1.
López Pupo N, Tablada Robinet ME, Jacas Portuondo AL, Baltazar Green A, González Vázquez LF. Risk factors and comorbidities in patients with psoriasis. MEDISAN [Internet]. 2019 Jun. 11 [cited 2025 Jun. 22];23(3):435-46. Available from: https://medisan.sld.cu/index.php/san/article/view/2563

Issue

Vol. 23 No. 3 (2019): mayo-junio

Section

Original Articles

License

All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.